We confirmed that utilization of blocking antibody targeting CD29 specifically prevents arsenic-induced monocytes adhesion to VCAM-1, suggesting the biological importance of this integrin in arsenic-induced atherosclerosis. This evidence concerns the gene ITGB1 and atherosclerosis.